Skip to main content
. Author manuscript; available in PMC: 2022 Jul 6.
Published in final edited form as: J Adolesc Health. 2019 Nov 19;66(1):100–106. doi: 10.1016/j.jadohealth.2019.07.022

Table 4.

Results of sensitivity analysis on NIA and NAPa

Black ASMM White ASMM
25th percentile value 75th percentile value 25th percentile value 75th percentile value
PrEP costs ($) 80,097,883 82,476,372 82,530,747 84,828,878
Lifetime treatment cost averted ($) 41,731,126 82,246,082 6,833,454 27,223,859
Lifetime QALYs gained 388 765 64 253
ICER ($/QALY gained) 98,785 301 1,190,247 227,357

ASMM = adolescent sexual minority males; ICER = incremental cost-effectiveness ratio; NAP = number of ASMM on PrEP; NIA = number of infections averted; PrEP = pre-exposure prophylaxis; QALY quality-adjusted life years.

a

The cost-effectiveness was assessed using the 25th and 75th percentile values of NIA and NAP of 100 simulation runs.